Tag: biotech

Asset Allocation July 1, 2024

How Memorial Sloan Kettering Funds Its Cancer Fight

Under CIO Jason Klein, the celebrated hospital has leveraged its top-notch research and well-managed investments to produce still more breakthroughs.

Research May 30, 2023

Biotech Investment Could Be Approaching a ‘Golden Age’

J.P. Morgan strategist Jared Gross sketches out how small life sciences firms are now well-placed due to higher federal research funding and a more receptive FDA.

CIO-032422 OSC2-Biotech trends_Scott Bakal-web

Asset Allocation March 24, 2022

Up and Coming Biotech Innovations Investors Should Know About

Investors name some key companies and strategies they see promise in.

Asset Allocation November 2, 2021

What Corporate Cash Use Helps Stocks Most in the Pandemic?

You’d think the answer is stock buybacks. Guess again, says Goldman.

Asset Allocation October 4, 2021

Get Ready for a Biotech M&A Comeback

RBC Capital, heartened by some billion-dollar-plus deals, sees a new buyout hunger in Big Pharma.

Asset Allocation July 20, 2020

Temasek Boosts Cybersecurity and Biotech Investments

The Singapore sovereign wealth fund placed wagers on two American companies, cyber-services startup BlueVoyant and biosensors business Glympse Bio.

November 7, 2019

Gene Therapy: For Investors, a Source of Dreams—and Duds

Ingenious science, when it doesn’t pan out, can bring volatile stock performance.